Merck KGaA announced the successful completion of its acquisition of Millipore. The closing follows the approval of the acquisition by Millipore’s shareholders and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe. With 10,000 employees in 64 countries, EMD Millipore (Merck Millipore outside U.S. and Canada) will be headquartered in Billerica, Massachusetts, with locations throughout the Americas, Europe and Asia-Pacific.
The division will offer a comprehensive range of products, technologies and services for pharma and biotech companies, as well as for academia, to improve laboratory productivity and develop and optimize manufacturing processes. EMD Millipore will have enhanced global manufacturing and distribution capabilities. EMD Millipore will consist of three business units – Bioscience, Lab Solutions and Process Solutions – and each unit will comprised of a number of key focus areas, known as business fields. Merck KGaA, +49-6151-72-0, http://www.merck.de/